The impact of copay assistance on patient out-of-pocket costs and treatment rates with ALK inhibitors.

CONCLUSION: Copay assistance reduced the patient cost burden for ALKis and was associated with patients picking up their ALKi prescriptions, beginning ALKi treatment sooner, and remaining on treatment. PMID: 30729850 [PubMed - as supplied by publisher]
Source: Journal of Medical Economics - Category: Health Management Tags: J Med Econ Source Type: research